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Abstract: 
Large genomic sequencing projects of pathogens as well as human genome leads to immense genomic and proteomic data which would be very 
beneficial for the novel target identification in pathogens. Subtractive genomic approach is one of the most useful strategies helpful in 
identification of potential targets. The approach works by subtracting the genes or proteins homologous to both host and the pathogen and 
identify those set of gene or proteins  which are  essential  for  the  pathogen  and are  exclusively  present  in the  pathogen. Subtractive genomic 
approach is employed to identify novel target in salmonella typhi. The pathogen has 4718 proteins out of which 300 are found to be essential 
(“indispensable to support
 cellular life”) in the pathogen with no human homolog. Metabolic pathway analyses of these 300 essential proteins 
revealed that 149 proteins are exclusively involved in several metabolic pathway of S. typhi. 8 metabolic pathways are found to be present 
exclusively in the pathogen comprising of 27 enzymes unique to the pathogen. Thus, these 27 proteins may serve as prospective drug targets. 
Sub-cellular localization prediction of the 300 essential proteins was done which reveals that 11 proteins lie on the outer membrane of the 
pathogen which could be probable vaccine candidates.  
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Background: 
The  availability  of  large  amount  of  genomic  data  generated by  
the  microbial  genomes  and the  human genome project has 
revolutionized the field of drug-discovery against threatening human 
pathogens  [1]. These large sets of genomic data are useful in 
identification and characterization of the novel therapeutic targets and 
virulent factors prevalent in the pathogens. Subtractive genomic 
strategy is developed by assuming that the novel targets identified in 
the pathogen should be  essential  for  the  pathogen that  is  it  should 
be  involved in the  replication, survival  and a important component 
of various metabolic pathways and mechanisms occurring in the 
pathogen while at the same time should be absent on the host that is 
human and should have no homolog in human, so that when a drug or 
a lead compound is designed considering the potential target it should 
only be against the mechanism and functionality of the pathogen  not 
the host. Subtractive genomics has been successfully used by authors 
to locate novel drug targets in Pseudomonas aeruginosa [2]. The work 
has been effectively complemented with the compilation of the 
Database of Essential Genes (DEG) for a number of pathogenic 
microorganisms [3]. The current studies make use of the subtractive 
genomics approach and DEG to analyze the complete genome of 
Salmonella typhi to search for potential vaccine candidates which 
would possibly lie on the surface membrane of the pathogen and drug 
targets.   
 
Salmonella enterica serovar typhi is a human-specific gram-negative 
pathogen causing enteric typhoid fever, a severe infection of the 
reticuloendothelial system [4], [5], [6].  It has two strains CT18 
(multiple drug resistant) [7] and Ty with a complete proteome of 4718 
proteins. Worldwide, typhoid fever affects roughly millions of people 
annually, causing deaths. Infection of S. typhi leads to the development 
of typhoid, or enteric fever.  This  disease  is  characterized by  the  
sudden onset  of  a  sustained and systemic  fever,  severe headache, 
nausea, and loss of appetite. Other symptoms include constipation or 
diarrhea, enlargement of the spleen, possible development of 
meningitis, and/or general depression. Untreated typhoid fever  cases 
result  in mortality  rates  ranging  from  12-30%  while  treated cases  
allow  for  99%  survival. The early administration of antibiotic 
treatment has proven to be highly effective  in eliminating infections, 
but  indiscriminate  use  of  antibiotics  has  led to the  emergence of 
multidrug-resistant strains of  S.  enterica serovar  Typhi  [8]. 
Chloramphenicol was the drug for the treatment of this infection till 
plasmid mediated chloramphenicol resistance was encountered [9]. 
Following this ciprofloxacin became the mainstay of treatment being a 
safer and more effective drug than Chloramphenicol but after clinical 
resistance to treatment with ciprofloxacin in the patients suffering 
from enteric fever, the choice left now is an expensive drug like 
ceftriaxone or cefexime.[10]. Resistance against ceftriaxone have been 
reported to CDC (Centre for Drug Control) [11] mild to moderate side 
effects have been shown for ceftriaxone. The novel targets identified 
by us using subtractive genomics will help enable understanding the 
biology of the pathogen to provide a more cost effective medication. 
 
Methodology: 
The systematic identification and characterization of potential targets 
in salmonella typhi is illustrated in Figure 1.  
 
Retrieval of proteomes of host and pathogen:  
The complete proteome of Salmonella typhi were retrieved from 
SwissProt  [12] and protein sequences of Homo sapiens were 
downloaded from NCBI [13]. The Database of Essential genes was 
accessed from its location http://tubic.tju.edu.cn/deg/.  
  
Identification of essential proteins in S. typhi: 
The  S. typhi proteins were purged at 60% using CD-HIT [14] to 
identify the paralogs or duplicates proteins within the proteome of 
S.typhi. The paralogs are excluded and the remaining sets of protein 
were subjected to BlastP against Homo sapiens protein sequences with 
the expectation value (E-value) cutoff of 10
-4
. The resultant dataset 
obtained were with no homologs in Homo sapiens. BLASTP  analysis  
was  performed  for  the  non homologous  protein sequences  of  S. 
typhi against DEG with E-value cutoff score of 10
-100. A minimum bit-
score cut-off of 100 was used to screen out genes that appeared to 
represent essential genes. The protein sequences obtained are non 
homologous essential proteins of S.typhi.  
 
Metabolic pathway analysis: 
Metabolic pathway analysis of the essential proteins of S. typhi was 
done by KAAS server at KEGG for the identification of potential 
targets.  KAAS (KEGG Automatic Annotation Server) provides 
functional annotation of genes by BLAST comparisons against the 
manually curated KEGG GENES database. The result contains KO 
(KEGG Orthology) assignments and automatically generated KEGG 
pathways. [15]   Bioinformation   open access 
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Figure 1: Flow chart for systematic identification and characterization of potential targets in salmonella typhi. 
 
Sub-cellular Localization prediction: 
Protein sub cellular localization prediction involves the computational 
prediction of where a protein resides in a cell. Prediction of protein sub 
cellular localization is an important component as it predicts the 
protein function and genome annotation, and it can aid the 
identification of targets. Sub-cellular  localization  analysis  of  the 
essential protein sequences  has  been  done  by  Proteome  Analyst  
Specialized Subcellular  Localization Server  v2.5 (PA-SUB)  [16]  to 
identify  the  surface  membrane  proteins  which could be probable 
vaccine candidates.   
 
Discussion: 
The results obtained through computational analysis reveals that out of 
4718 proteins in salmonella typhi 159 were identified as duplicates 
through CD-HIT with 60% similarity. The remaining 4559 paralogs 
were subjected to subtractive genomics which leads to 3570 proteins. 
These 3570 proteins when subjected to blastp against DEG database 
showed 300 proteins, which were essential for the pathogen. The 
results for subtractive proteome approach, metabolic pathway analysis 
and sub cellular localization are listed in Table No. 1(Supplementary 
material). The  purpose  of  the  present  studies  was  to  locate  those  
essential proteins of S. typhi  that play vital roles in the normal 
functioning of the bacterium within the host and to pick out them in 
the view of targeting. Detection of non-human homologs in the 
essential proteins of S. typhi with subsequent screening of the 
proteome to find the resultant protein product are likely to lead to 
development  of  drugs  that  exclusively  interact  with the  pathogen. 
The non-human homologs of the surface proteins would represent 
potential vaccine candidates. 300 of the essential proteins were 
without human homologs.  Metabolic pathway analyses of these 300 
essential proteins by KAAS server at KEGG revealed that out of 300, 
149 proteins might be concluded to be unique and are invariably 
linked with essential metabolic and signal transduction pathways. 
Presumably, screening  against  such novel  targets for functional   
inhibitors  will  result  in discovery  of  novel  therapeutic  compounds  
active  against  bacteria, including the increased number of antibiotic 
resistant clinical strains [17].   
 
Metabolic  pathway  analyses of the 149 essential  proteins  revealed  
that 15 proteins are involved in Carbohydrate Metabolism,  10 in 
Energy Metabolism, 5 in Lipid Metabolism,   4 in  Nucleotide   
Metabolism, 30 in Amino  Acid Metabolism, 20 in  Glycan 
Biosynthesis  and Metabolism, 16 in Metabolism  of  Co-factors  and 
Vitamins, 20 in genetic  information processing, 26 in environmental  
information processing  and  2   in human disease. The results are 
summarized in Table 2 (Supplementary material). Comparative Bioinformation   open access 
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analysis of the metabolic pathways of the host (Homo sapiens) and the 
pathogen (S.typhi) by using Kyoto Encyclopedia of Genes and 
Genomes (KEGG) reveals 8 pathways which are unique to S.typhi. 
Thereafter, each selected pathway was screened for the unique 
enzymes and proteins involved. The peptidoglycan layer of the 
bacterial cell wall is the major structural element which plays an 
important role in pathogenesis as it provides resistance to osmotic 
lysis. D-alanine is the central molecule in the peptidoglycan assembly 
and cross-linking. D-alanine-D-alanine ligase (ddlA) is an important 
target as it is involved in D-alanine metabolism. Lipopolysaccharides 
(LPS) are also one of the main constituents of the outer cell wall of 
gram negative bacteria and play an important role for the survival of 
the pathogen. Out of the 14 enzymes involved in LPS biosyntheseis 
pathway, 13 enzymes are found to be essential for the variability of the 
bacteria and could be probable drug targets and it did not show 
homology with any human protein. 
 
Two-component systems of bacteria represent the primary signal 
transduction paradigm in prokaryotic organisms. 8 essential enzymes 
were found to be potential targets in this pathway. Tryptophan 
synthase beta chain (trpB) is an important enzyme as it is involved in 
tyrosine and tryptophan biosynthesis pathway. Chemotaxis protein 
(MotA) and chemotaxis protein methyltransferase (CheR) is essential 
enzyme due to its involvement in multiple metabolic pathways like 
cell Motility, bacterial chemotaxis and flagellar assembly. 
Phosphoenolpyruvate (ppc) has been identified as a possible target due 
to its involvement in carbon fixation in photosynthetic organism, 
pyruvate metabolism and reductive carboxylase cycle. The focus of 
the present studies was to hunt for potential targets in S. typhi by 
computational approach. The sub-cellular localization prediction done 
by PA-SUB identify 11 proteins lying on the surface of the pathogen 
which could represent  promising  candidates  for  further   
characterization and analysis  with a support to vaccine design. The 
results are summarized in Table No. 3 (Supplementary material)  
 
Conclusion: 
The availability of full genomic and proteomic sequences generated 
from the sequencing projects along with the computer-aided softwares 
to identify and characterize probable drug targets is a new emerging 
trend in pharmacogenomics . The application of the Database of 
essential genes helps to identify the potential drug targets in 
pathogens. The current study helps in the characterization of the 
potential proteins that could be targets for efficient drug design against 
Salmonella typhi. As subtractive genomic approach is applied for the 
identification of drug targets, so the drug would be specific for the 
pathogen and not lethal to the host. Molecular modeling of the targets 
will decipher the best possible active sites that can be targeted by 
simulations for drug design. Virtual screening against these potential 
targets might be useful in the discovery of potential therapeutic 
compounds against Salmonella typhi.   
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Supplementary material 
 
Table 1: Substractive proteomic and metabolic pathway analysis result for Salmonella typhi 
Salmonella typhi   Number 
Total Number of proteins  4718 
Duplicates (>60% identical) in CD-HIT  159 
Non-paralogs 4559 
Non-human homologous proteins (E-value 10
-4) 3570 
Essential protein in DEG (E-value 10
-100) 300 
Essential proteins involved in metabolic pathways  149 
Pathways unique to the organism (S.typhi) 8 
Proteins involved in unique pathways  27 
Membrane associated non-human homologs of essential genes  11 
 
Table 2: Essential proteins of S.typhi involved in several metabolic pathways 
SN KO  Protein  Name  Gene  Name  Pathway  EC 
Metabolism  
Carbohydrate metabolism  
1  K02777  glucose-specific IIA component crr  Phosphotransfe-rase 
system  
EC:2.7.1.69 
2  K01643  citrate lyase subunit alpha citF  Environmental   
Information Processing 
EC:4.1.3.6 
3 K00117  Quinoprotein  dehydrogenase glucose  gcd  Pentose pathway 
phosphate  
EC:1.1.1.130 
4 K08092  3-dehydro-L-gulonate  2-Dehydrogenase E1.1.1.130  Pentose  and glucuronate  
Interconversions 
EC:1.1.1.130 
5  K02798  mannitol-specific IIA component   mtlA  Phosphotransfe-rase 
system  
EC:2.7.1.69  
6 K01818 
 
L-fucose isomerase  
 
fucI  Fructose  and  mannose  
metabolism  
EC 5.3.1.25  
 
7  K02821  ascorbate-specific IIA component sgaA  Phosphotransfe-rase 
system  
EC:2.7.1.69 
8 K01788  -acylglucosamine-6- 
phosphate 2-epimerase 
nanE  Aminosugars metabolism     EC:5.1.3.9 
9 K03431  phosphoglucosamine  mutase  glmM  Aminosugars metabolism    EC:5.4.2.10 
10  K00790  UDP-N-acetylglucosamine  1- 
carboxyvinyltransferase 
murA  Aminosugars metabolism    EC:2.5.1.7 
11 K00075  UDP-N-acetylmuramate   
dehydrogenase 
murB  Aminosugars metabolism    EC:1.1.1.158 
12 K01595  phosphoenolpyruvate   
carboxylase  
Ppc Pyruvate  metabolism  EC:4.1.1.31 
13 K00656  formate  C-acetyltransferase  pflD Pyruvate  metabolism  EC:2.3.1.54 
14 K00925  acetate  kinase  ackA  Pyruvate  metabolism  EC:2.7.2.1 
15 K00932  propionate  kinase  tdcD  Propanoate metabolism  EC:2.7.2.15 
Energy metabolism  
1  K00425  cytochrome bd-I oxidase  subunit I   cydA  Oxidative  
phosphorylation  
EC:1.10.3 
2  K00426  cytochrome bd-I oxidase  subunit I  
 
cydB Oxidative   
phosphorylation  
EC:1.10.3 
3 K01595  phosphoenolpyruvate   
carboxylase  
Ppc Pyruvate  metabolism   
 
EC:4.1.1.31 
4  K00926   carbamate kinase  arc  Nitrogen metabolism  EC:2.7.2.2 
5 K01916  NAD+  synthase  NadE  Nitrogen metabolism  EC:6.3.1.5 
6 K01914  aspartate--ammonia  ligase  AsnA Nitrogen  metabolism  EC:6.3.1.1 
7  K00264  Glutamate synthase (NADPH/NADH)  GLT1  Nitrogen  metabolism  EC:1.4.1.13   
1.4.1.14  
8 K03385  formate-dependent  nitrite reductase   NrfA  Nitrogen metabolism  EC:1.7.2.2 
9 K00369  nitrate  reductase  E1.7.99.4 Nitrogen  metabolism  EC:1.7.99.4 
10 K00640  serine  O-acetyltransferase  CysE  Sulfur metabolism    EC:2.3.1.30 
Lipid metabolism  
1  K00648  3-oxoacyl-[acyl-carrier-protein] synthase III   fabH  Fatty acid biosynthesis   EC:2.3.1.180 
2 K03527  4-hydroxy-3-methylbut-2-enyl diphosphate reductase  ispH  Biosynthesis of steroids  EC:1.17.1.2 
3 K03526  (E)-4-hydroxy-3-methylbut-  2-enyl-diphosphate synthase   ispG  Biosynthesis of steroids  EC:1.17.7.1 
4 K00919  4-diphosphocytidyl-2-C-methyl-D-erythritol  kinase   ispE  Biosynthesis of steroids  EC:2.7.1.148 
5 K00099  1-deoxy-D-xylulose-5- 
phosphate reductoisomerase  
Dxr  Biosynthesis of steroids  EC:1.1.1.267 Bioinformation   open access 
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Nucleotide metabolism  
1  K00951  GTP pyrophosphokinase  relA  Purine metabolism   EC:2.7.6.5 
2  K09903  uridylate kinase  pyrH   Pyrimidine metabolism  EC:2.7.4.22 
3  K03040  DNA-directed RNA polymerase subunit alpha  rpoA  Genetic Information 
Processing 
EC:2.7.7.6 
4  K02319  DNA polymerase I  polB1  Purine metabolism  EC:2.7.7.7 
Amino acid metabolism  
1  K00926  carbamate kinase  arc   Glutamate metabolism   EC:2.7.2.2 
2  K01776    glutamate racemase   murI  Glutamate metabolism  EC:5.1.1.3 
3  K01775  alanine racemase  Alr  Alanine and aspartate  
metabolism  
EC:5.1.1.1 
4 K01270  aminoacylhistidine  dipeptidase   pepD  Alanine and aspartate  
metabolism  
EC:3.4.13.3 
5 K00003  homoserine  dehydrogenase thrA  Glycine,serine  and 
threonine metabolism  
EC:1.1.1.3 
6 K00133  aspartate-semialdehyde   
dehydrogenase  
asd Glycine,serine  and 
threonine metabolism  
EC:1.2.1.11 
7 K00549  5-  methyltetrahydropteroyltriglu 
tamate—homocysteine  
metE Methionine  metabolism  EC:2.1.1.14 
8 K01243  S-adenosylhomocysteine/5'- 
methylthioadenosine nucleosidase  
mtnN, mtn,pfs   Methionine metabolism  EC:3.2.2.9 
9  K00215  dihydrodipicolinate reductase    dapB  Lysine biosynthesis   EC:1.3.1.26 
10 K00674  2,3,4,5-tetrahydropyridine-2- 
carboxylate N-succinyltransferase  
dapD  
 
Lysine biosynthesis   EC:2.3.1.117 
11 K01778  diaminopimelate  epimerase  dapF  Lysine biosynthesis   EC:5.1.1.7 
12 K01929  UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-
diaminopimelate--D-alanyl- D-alanine ligase 
murF  
 
Lysine biosynthesis  
 
EC:6.3.2.10 
13 K01928  UDP-N-acetylmuramoylalanyl-D- 
glutamate--2,6-diaminopimelate ligase  
murE  Lysine biosynthesis  
 
EC:6.3.2.13 
14  K01484  succinylarginine dihydrolase  astB  Arginine and proline 
metabolism  
EC:3.5.3.23 
15  K00673  arginine N-succinyltransferase  astA  Arginine and proline 
metabolism  
EC:2.3.1.109 
16  K00765  ATP phosphoribosyltransferase   hisG  Histidine metabolism   EC:2.4.2.17 
17 K01523  phosphoribosyl-ATP  pyrophosphohydrolase   hisE  Histidine  metabolism    EC:3.6.1.31 
18  K01496  phosphoribosyl-AMP cyclohydrolase   hisI   Histidine metabolism   EC:3.5.4.19 
19 K01693  imidazoleglycerol-phosphate  dehydratase   hisB  Histidine metabolism   EC:4.2.1.19 
20 
 
K01089 imidazoleglycerol-phosphate dehydratase / histidinol-
hosphatase 
hisB Histidine  metabolism   
 
EC:4.2.1.19  
3.1.3.15  
21 K01626  3-deoxy-7- 
phosphoheptulonate synthase  
aroF,aroG, 
aroH 
Phenylalanine, tyrosine 
and tryptophan 
biosynthesis  
EC:2.5.1.54 
22 K01735  3-dehydroquinate synthase  ARO1  Phenylalanine, tyrosine 
and tryptophan 
biosynthesis  
EC:4.2.3.4 
23  K01696  Tryptophan synthase beta  
chain  
trpB Phenylalanine,  tyrosine 
and tryptophan 
biosynthesis  
EC:4.2.1.20  
 
24  K01695  Tryptophan synthase  alpha  
chain  
trpA Phenylalanine,  tyrosine 
and tryptophan 
biosynthesis  
EC:4.2.1.20 
25  K01736  chorismate synthase  aroC  Phenylalanine, tyrosine 
and tryptophan 
biosynthesis  
EC:4.2.3.5 
26 K01850  chorismate  mutase  E5.4.99.5 
 
Phenylalanine, tyrosine 
and tryptophan 
biosynthesis  
EC:5.4.99.5 
27  K00145  N-acetyl-gamma-glutamyl- phosphate reductase  
 
argC  Urea  cycle And 
metabolism of amino 
groups  
EC:1.2.1.38 
Metabolism of another amino acids  
1 K01925  UDP-N-acetylmuramoylalanine--D- 
glutamate ligase  
murD  
 
D-Glutamine and 
D-glutamate metabolism 
EC:6.3.2.9 
2 K01924  UDP-N-acetylmuramate-- 
alanine ligase  
murC D-Glutamine  and 
D-glutamate metabolism 
EC:6.3.2.8 
3  K01921  D-alanine-D-alanine ligase  ddlA  D-Alanine metabolism   EC:6.3.2.4 
Glycan biosynthesis and metabolism  
1 K00677  UDP-N-acetylglucosamine    lpxA Lipopolysaccharide  EC:2.3.1.129 Bioinformation   open access 
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acyltransferase biosynthesis   
2 K02535  UDP-3-O-[3-hdroxymyristoyl]  N-  acetylglucosamine 
deacetylase 
lpxC Lipopolysaccharide   
biosynthesis  
EC:3.5.1. 
3  K02536  UDP-3-O-[3- hydroxymyristoyl]  
glucosamine N-acyltransferase  
lpxD Lipopolysaccharide   
biosynthesis  
EC:2.3.1.  
 
4 K03269  UDP-2,3-diacylglucosamine   
hydrolase  
lpxH Lipopolysaccharide   
biosynthesis  
EC:3.6.1.  
 
5  K00748  lipid-A-disaccharide synthase  lpxB  Lipopolysaccharide  
biosynthesis  
EC:2.4.1.182 
6  K00912  tetraacyldisaccharide 4'-kinase  lpxK  Lipopolysaccharide  
biosynthesis  
EC:2.7.1.130  
 
7 K02527  3-deoxy-D-manno-octulosonic-acid transferase   kdtA  Lipopolysaccharide  
biosynthesis  
EC:2.-.-.-  
8 K00979  3-deoxy-manno-octulosonate cytidylyltransferase kdsB  Lipopolysaccharide   
biosynthesis  
EC:2.7.7.38 
9 K01627  2-dehydro-3-deoxyphosphooctonate aldolase kdsA  Lipopolysaccharide   
biosynthesis  
EC:2.5.1.55 
10  K02841  heptosyltransferase I  waaC, rfaC  Lipopolysaccharide  
biosynthesis  
EC:2.4.-.-  
 
11  K02843  heptosyltransferase II  waaF, rfaF  Lipopolysaccharide  
biosynthesis  
EC:2.4.-.-  
 
12 K02840  Galactosyltransferase  waaB,  rfaB  Lipopolysaccharide   
biosynthesis  
EC:2.4.1.- 
13 
 
K02844 Glucosyltransferase  waaG, rfaG  Lipopolysaccharide  
biosynthesis  
EC:2.4.1.-  
 
14  K02847  O-antigen ligase  waaL, rfaL  Lipopolysaccharide  
biosynthesis  
EC:6.-.-.-  
 
15 K01921  D-alanine-D-alanine  ligase  ddlA  Peptidoglycan 
biosynthesis  
EC:6.3.2.4 
16 K01000  phospho-N-acetylmuramoyl-pentapeptide-transferase mraY    Peptidoglycan 
biosynthesis  
EC:2.7.8.13 
17 K02563  UDP-N-acetylglucosamine--N-acetylmuramyl-
(pentapeptide) pyrophosphoryl-undecaprenol  
N-acetylglucosamine transferase  
murG  
 
Peptidoglycan 
biosynthesis  
EC:2.4.1.227 
18  K01924  UDP-N-acetylmuramate-alanine ligase   murC  Peptidoglycan 
biosynthesis  
EC:6.3.2.8 
19 K01925  UDP-N-acetylmuramoylalanine--D-glutamate ligase   murD  Peptidoglycan 
biosynthesis  
EC:6.3.2.9 
20  K03587  cell division protein FtsI ftsI  Peptidoglycan 
biosynthesis  
EC:2.4.1.129  
Metabolism of Co-factors and Vitamins  
1  K03147  thiamine  biosynthesis  protein ThiC   thiC  Thiamine metabolism    
2  K00946  thiamine-monophosphate kinase   thiL Thiamine  metabolism  EC:2.7.4.16 
3  K01497  GTP cyclohydrolase II  ribA  Riboflavin metabolism   EC:3.5.4.25  
4 K01498  diaminohydroxyphosphoribosylaminopyrimidine deaminase  E3.5.4.26 
 
Riboflavin metabolism   EC:3.5.4.26 
5 K00082  5-amino-6-(5-phosphoribosylamino) uracil reductase   E1.1.1.193  Riboflavin metabolism   EC:1.1.1.193 
6  K02858  3,4-dihydroxy  2-butanone  4-phosphate synthase   ribB  Riboflavin metabolism    
7  K00793  riboflavin synthase alpha chain   ribE  Riboflavin  metabolism    EC:2.5.1.9 
8 K03474  pyridoxine  synthase 5-phosphate   pdxJ  Riboflavin metabolism   EC:2.6.99.2 
9  K00969  nicotinate-nucleotide adenylyltransferase  nadD  
 
Nicotinate and 
nicotinamide metabolism  
EC:2.7.7.18 
10 K03517  quinolinate  synthase nadA  Nicotinate  and 
nicotinamide metabolism  
 
11  K01012  biotin synthetase  bioB  Biotin metabolism   EC:2.8.1.6 
12 K01664  para-aminobenzoate synthetase  
component II  
pabA  Folate biosynthesis   EC:2.6.1.85 
13  K02302  uroporphyrin-III C- methyltransferase  /  precorrin-2 
dehydrogenase /  sirohydrochlorin ferrochelatase  
cysG  Porphyrin and chlorophyll 
metabolism 
EC:2.1.1.107 
1.3.1.76  
4.99.1.4  
14 K02492  glutamyl-tRNA  reductase  hemA   
 
Porphyrin and chlorophyll 
metabolism 
EC:1.2.1.70 
15  K02551    2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1- 
carboxylate synthase  
mend  Ubiquinone and  
menaquinone biosynthesis  
EC:2.2.1.9 
16 K03182  3-octaprenyl-4-hydroxybenzoate   
carboxy- lyase UbiD  
ubiD  Ubiquinone and  
menaquinone biosynthesis  
EC:4.1.1.- 
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1 K06281  hydrogenase  large  subunit  E1.12.99.6L    Xenobiotics  and 
biodegradation 
metabolism  
EC:1.12.99.6 
Genetic information processing  
Transcription 
1  K03040  DNA-directed RNA polymerase subunit alpha  rpoA  RNA polymerase  
 
EC:2.7.7.6 
Translation  
 
1  K02986  small   subunit ribosomal RP-S4, rotein S4  rpsD  Translation   
2  K01878  glycyl-tRNA  synthetase  alpha chain  glyQ  Aminoacyl-tRNA 
biosynthesis 
EC:6.1.1.14 
Folding, sorting and degradation  
1  K03070  Preprotein translocase SecA  subunit  secA  Folding, Sorting and 
Degradation 
 
2  K03076  preprotein  translocase  SecY subunit  secY  Folding,  Sorting  and 
Degradation 
 
3  K03072  Preprotein translocase  SecD subunit   secD  Folding,  Sorting  and 
Degradation 
 
 
4  K03074  preprotein  translocase  SecF subunit   secF  Folding,  Sorting  and 
Degradation 
 
Replication and Repair  
 
1  K02342  DNA  polymerase  III  subunit DPO3E, epsilon  dnaQ  DNA replication   EC:2.7.7.7 
2  K02337  DNA  polymerase  III  subunit DPO3A1, alpha   dnaE  DNA Replication  EC:2.7.7.7 
3  K02341  DNA  polymerase  III  subunit DPO3D2, delta  holB  DNA Replication  EC:2.7.7.7 
4  K02338  DNA  polymerase  III  subunit DPO3B, beta  dnaN  DNA Replication  EC:2.7.7.7 
5  K02340  DNA  polymerase  III  subunit DPO3D1, delta  holA  DNA Replication  EC:2.7.7.7 
6  K02314  replicative DNA helicase  dnaB  DNA Replication  EC:3.6.1.- 
7  K02316  DNA primase  dnaG  DNA Replication  EC:2.7.7.- 
8  K03657  DNA  helicase  II  /  ATP- 
dependent DNA helicase PcrA 
uvrD, pcrA  Nucleotide excision repair   EC:3.6.1.- 
9  K01141  exodeoxyribonuclease I  sbcB  Mismatch repair  EC:3.1.11.1 
10  K03582  exodeoxyribonuclease  V  beta subunit   recB  Homologous 
recombination  
EC:3.1.11.5 
11  K03583  exodeoxyribonuclease gamma subunit V  recC  Homologous 
recombination 
EC:3.1.11.5 
12  K03629  DNA  replication and  repair protein RecF  recF  Homologous 
recombination 
EC:3.1.11.5 
13  K04066  primosomal protein N'  priA  Homologous 
recombination 
EC:3.6.1.- 
Environmental Information Processing  
Membrane Transport 
1  K02047  sulfate transport system permease protein  cysW   ABC transporters   
2  K11070  spermidine/putrescine transport system permease protein  potC  ABC Transporters   
3 K11069  spermidine/putrescine  transport system substrate-binding 
protein 
potD  
 
ABC transporters   
4 
 
K10540  methyl-galactoside transport system 
protein 
mglB ABC  Transporters   
5  K02040  phosphate  transport  system substrate-binding protein  pstS   ABC Transporters   
6  K10015  histidine transport system permease protein  hisM  ABC Transporters   
7  K10002  glutamate/aspartate transport system permease protein  gltK  ABC Transporters   
8  K10009  cystine transport system permease protein   ABC.CYST.P  ABC Transporters   
9  K02035  peptide/nickel transport system  
substrate-binding protein 
ABC.PE.S 
 
ABC Transporters   
10  K02016  iron complex  transport  system substrate-binding protein  ABC.FEV.S    ABC Transporters   
11 K09808  lipoprotein-releasing  system permease protein  ABC.LPT.P, 
lolC, lolE 
ABC Transporters   
12  K09811  cell  division transport  system permease protein   ftsX  ABC Transporters   
13  K07091  lipopolysaccharide export system permease protein   lptF  ABC Transporters   
14  K11720  lipopolysaccharide export  system permease protein  lptG  ABC transporters   
15  K02778  PTS  system, glucose-specific IIB component  PTS-Glc- 
EIIB, ptsG  
  
16  K03475  PTS system, ascorbate-specific IIC component   PTS-Ula- 
EIIC, laA,  
sgaT 
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17  K08484  phosphotransferase  system, enzyme I, PtsP   PTS- 
EI.PTSP, 
ptsP 
  
Signal Transduction 
1 K07636  two-component  system,  OmpR family, phosphate regulon 
sensor histidine kinase PhoR 
PhoR Signal  Transduction  EC:2.7.13.3 
2  K07639  two-component system, OmpR family, sensor  histidine   
kinase RstB 
RstB Signal  Transduction  EC:2.7.13.3 
3  K02556  chemotaxis protein MotA motA  Signal  Transduction   
4  K00370  nitrate  reductase  1,  alpha  subunit narG  Signal  Transduction  EC:1.7.99.4 
5 K00990  [protein-PII]  uridylyltransferase glnD  Signal  Transduction EC:2.7.7.59 
6  K03407  two-component system, chemotaxis family, sensor kinase 
CheA 
cheA Signal  Transduction  EC:2.7.13.3 
7  K00575  chemotaxis protein methyltransferase CheR  cheR   Signal Transduction  EC:2.1.1.80 
Human Diseases 
Infectious Diseases 
1  K03092  RNA  polymerase  sigma-54 factor  SIG54, rpoN    Vibrio  cholerae 
phathogenic cycle 
 
2  K05851    adenylate cyclase, class 1  E4.6.1.1A, 
cyaA 
Vibrio cholerae 
phathogenic cycle 
EC:4.6.1.1 
 
Table 3: List of the outer membrane proteins of Salmonlla typhi identified by PA-SUB  
S.N  Accession No  Name of Protein  Sub-Cellular Localization 
1  Q56110  Outer membrane prorein S1  Outer membrane 
2  Q56119  Outer membrane pore protein   Outer membrane 
3  Q8Z8P3  Outer membrane usher protein FimD  Outer membrane 
4  Q8Z944  Outer membrane fimbrial usher protein   Outer membrane 
5  Q8Z4Y8  Long chain fatty acid transport protein  Outer membrane 
6  Q8Z1S4  Putative Type-I section protein  Outer membrane 
7  Q8XEL5  Putative exported protein  Outer membrane 
8  Q8Z9A3  Outer membrane protein assembly factor yaeT  Outer membrane 
9 Q8Z9J6  LPS-assembly  protein  Outer  membrane 
10 Q8Z4J0  Putative  lipoprotein  Outer  membrane 
11  Q8Z6A0  Outer membrane lipoprotein lolB  Outer membrane 
 
 
 